RETSAT
Basic information
Region (hg38): 2:85341955-85354531
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RETSAT gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 45 | 48 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 2 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 45 | 3 | 6 |
Variants in RETSAT
This is a list of pathogenic ClinVar variants found in the RETSAT region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-85343258-T-G | not specified | Uncertain significance (Oct 26, 2022) | ||
2-85343262-C-T | not specified | Uncertain significance (Jan 08, 2024) | ||
2-85343265-G-A | not specified | Uncertain significance (Apr 26, 2023) | ||
2-85343265-G-T | Benign (Jul 12, 2018) | |||
2-85343307-G-A | not specified | Uncertain significance (Sep 17, 2021) | ||
2-85343343-G-T | not specified | Uncertain significance (Jun 02, 2024) | ||
2-85343355-C-G | not specified | Uncertain significance (Jun 02, 2023) | ||
2-85343375-T-C | not specified | Uncertain significance (Apr 25, 2023) | ||
2-85343376-C-A | not specified | Uncertain significance (Feb 14, 2023) | ||
2-85343657-G-T | not specified | Uncertain significance (Jan 03, 2022) | ||
2-85343674-C-T | not specified | Uncertain significance (Jan 03, 2022) | ||
2-85343699-G-A | not specified | Uncertain significance (Jun 01, 2023) | ||
2-85343704-C-T | not specified | Uncertain significance (Jan 18, 2023) | ||
2-85343770-A-G | not specified | Uncertain significance (Aug 17, 2021) | ||
2-85344042-G-A | not specified | Uncertain significance (Dec 15, 2023) | ||
2-85344072-TCA-T | Benign (Jul 12, 2018) | |||
2-85344087-C-T | not specified | Uncertain significance (Feb 23, 2023) | ||
2-85344118-C-G | not specified | Uncertain significance (Oct 05, 2023) | ||
2-85344243-G-T | not specified | Uncertain significance (Feb 16, 2023) | ||
2-85344262-G-A | not specified | Uncertain significance (Aug 10, 2021) | ||
2-85344281-A-G | not specified | Uncertain significance (Dec 18, 2023) | ||
2-85344309-C-T | Benign (Jun 12, 2018) | |||
2-85344310-G-A | Benign (Jul 12, 2018) | |||
2-85344663-C-T | not specified | Uncertain significance (Jul 14, 2021) | ||
2-85344666-C-T | not specified | Likely benign (Dec 28, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RETSAT | protein_coding | protein_coding | ENST00000295802 | 11 | 12533 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
6.83e-14 | 0.213 | 122995 | 29 | 2724 | 125748 | 0.0110 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.113 | 342 | 348 | 0.983 | 0.0000191 | 3914 |
Missense in Polyphen | 73 | 80.514 | 0.90668 | 920 | ||
Synonymous | -0.150 | 147 | 145 | 1.02 | 0.00000796 | 1279 |
Loss of Function | 1.08 | 24 | 30.5 | 0.788 | 0.00000191 | 302 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0295 | 0.0293 |
Ashkenazi Jewish | 0.00288 | 0.00288 |
East Asian | 0.0952 | 0.0593 |
Finnish | 0.0118 | 0.0118 |
European (Non-Finnish) | 0.00459 | 0.00455 |
Middle Eastern | 0.0952 | 0.0593 |
South Asian | 0.00644 | 0.00554 |
Other | 0.0113 | 0.00933 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the saturation of all-trans-retinol to all- trans-13,14-dihydroretinol. Does not exhibit any activity toward all-trans-retinoic acid, nor 9-cis, 11-cis or 13-cis-retinol isomers. May play a role in the metabolism of vitamin A. Independently of retinol conversion, may regulate liver metabolism upstream of MLXIPL/ChREBP. May play a role in adipocyte differentiation. {ECO:0000250|UniProtKB:Q64FW2}.;
- Pathway
- Retinol metabolism - Homo sapiens (human);Vitamin A Deficiency;Retinol Metabolism;Vitamin A and Carotenoid Metabolism;Signaling by GPCR;Signal Transduction;Metabolism of fat-soluble vitamins;Metabolism;Metabolism of vitamins and cofactors;Retinoid metabolism and transport;G alpha (i) signalling events;Visual phototransduction;GPCR downstream signalling
(Consensus)
Recessive Scores
- pRec
- 0.0935
Intolerance Scores
- loftool
- 0.956
- rvis_EVS
- 0.07
- rvis_percentile_EVS
- 59.16
Haploinsufficiency Scores
- pHI
- 0.111
- hipred
- N
- hipred_score
- 0.197
- ghis
- 0.494
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.462
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Retsat
- Phenotype
- hematopoietic system phenotype; homeostasis/metabolism phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan);
Gene ontology
- Biological process
- retinol metabolic process;oxidation-reduction process
- Cellular component
- nuclear outer membrane;endoplasmic reticulum membrane;membrane;nuclear membrane
- Molecular function
- oxidoreductase activity;all-trans-retinol 13,14-reductase activity